In the pharmaceutical industry, timelines serve as both operational benchmarks and market signals. When sponsors announce trial starts and milestones, the investment community pays close attention. But what happens when behind-the-scenes issues, such as delays in sourcing a comparator drug, throw those timelines off track? At Clinical Services International (CSI), we have seen firsthand how comparator drug sourcing, though often underestimated, can become a critical path depe

Rapid Supply of Abraxane in Europe Client Request: Urgent Need for Abraxane A global pharmaceutical sponsor was in a tight spot. They needed 450 packs of Abraxane (nab-paclitaxel) for sites across Europe. Unfortunately, their original supplier could not meet the demand within the required timeline. This situation threatened to delay patient enrolment and jeopardise key study milestones. The Challenge: Overcoming Obstacles The project faced several challenges: Short lead time

Your Global Partner in Clinical Trial Supply At Clinical Services International (CSI), we do more than source medicines, we ensure your...

CSI is proud to drive progress and celebrate the power of diversity. Our team is as global as the studies we support. Representing a...

In an industry where both timelines and budgets are under constant pressure, clinical trial sponsors and CROs are often forced to balance the two most critical resources: time and money. At Clinical Services International (CSI), we work with clients around the world navigating this challenge. And whilst cost control is understandably top of mind, it is often time, not price, that defines success. Price Matters… But Isn’t Everything Sponsors and CROs are understandably price-s

ASCO 2025 Signals a New Chapter in Myelofibrosis Care The 2025 ASCO Annual Meeting delivered early insights into the future of myelofibrosis (MF) treatments. For Clinical Services International (CSI), a trusted sourcing partner for global oncology trials, this represents a significant scientific milestone. What’s New in MF and Why It Matters JAK inhibitors continue to be foundational in MF treatment, with ruxolitinib remaining a strong first-line option. However, ASCO 2025 hi

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

We’re incredibly proud to announce that CSI has once again achieved the Platinum EcoVadis rating, for the second year in a row! This places us in the top 1% globally for sustainability, ethics and corporate responsibility. It’s an incredible accomplishment and a testament to the values we live by every day. A huge thank you to our dedicated team for making this possible, your commitment continues to set us apart.

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across borders, sponsors often ask: which is the bigger challenge, drug sourcing or the logistics that follow? At Clinical Services International (CSI), we believe the answer isn’t either/or. It’s how you manage both that determines trial success. Comparator Sourcing: A Global Jigsaw Puzzle Sourcing comparator drugs can be a significant challenge, p

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS) sourced across both the EU and USA. Their priorities included: Relatively Stable pricing over a 2-3 year period Best possible expiry dates to accommodate packaging timelines (losing 6-8 weeks in the process) Ensuring continuous supply by replenishing stock before expiry (~14-16 months) Bulk procurement in single large batches for efficiency in regular intervals Challenges Ma

So are we! We’re pleased to share that Jonathan Miller, CSI’s Head of Operations, North America, will be attending Jefferies New York 2025 this June. If you’re a pharmaceutical or biotech company with comparator drugs in your pipeline, from early planning to on-demand global delivery, Jonathan would be happy to connect. Clinical Services International specializes in supporting complex, high-value clinical trials across all therapeutic areas. 📅 Let’s set up a meeting to explo